![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 26751-26760, September 17, 1999
§,
¶
,
, and
From the
Laboratoire de Morphogenèse et
Signalisation Cellulaire, Centre National de la Recherche Scientifique,
UMR 144, Institut Curie, 26, rue d'Ulm, Paris 75248 Cedex 05 France
and the ¶ V.I.B., Flanders Interuniversity Institute of
Biotechnology (ViBO9), Department of Biochemistry, University of Ghent,
B-9000 Ghent, Belgium
| |
ABSTRACT |
|---|
|
|
|---|
Villin is an actin-binding protein of the
intestinal brush border that bundles, nucleates, caps, and severs actin
in a Ca2+-dependent manner in
vitro. Villin induces the growth of microvilli in transfected
cells, an activity that requires a carboxyl-terminally located KKEK
motif. By combining cell transfection and biochemical assays, we show
that the capacity of villin to induce growth of microvilli in cells
correlates with its ability to bundle F-actin in vitro but
not with its nucleating activity. In agreement with its importance for
microfilament bundling in cells, the KKEK motif of the
carboxyl-terminal F-actin-binding site is crucial for bundling in
vitro. In addition, substitutions of basic residues in a second site, located in the amino-terminal portion of villin, impaired its
activity in cells and reduced its binding to F-actin in the absence of
Ca2+ as well as its bundling and severing activities
in vitro. Altogether, these findings suggest that villin
participates in the organization and stabilization of the brush border
core bundle but does not initiate its assembly by nucleation of actin filaments.
Villin is a 92.5-kDa, tissue-specific actin-binding protein
associated with the microvillar actin core bundle of intestinal and
renal brush border, a highly organized structure implicated in
absorption (1-5). In vitro, villin caps, nucleates, severs, and bundles actin filaments in a Ca2+ and
phosphoinositide-regulated manner (see Fig. 1A and Refs. 6-9). Villin is composed of six repeats, each containing approximately 150 residues that together constitute the core domain followed by the
carboxyl-terminal headpiece domain of 87 residues (10-12). The core
domain retains Ca2+-dependent capping,
nucleating, and severing activity, whereas the carboxyl-terminal
headpiece domain is required for actin filament bundling and binds to
F-actin, independently of Ca2+ (10, 13).
Villin is structurally and functionally related to two classes of
proteins. The first group comprises Quail, a bundling
protein in Drosophila required for the formation of
cytoplasmic F-actin bundles in ovary nurse cells (14) as well as
protovillin of Dictyostelium that has been proposed to be an
ancestral form of villin (15). The second group includes the severing
proteins gelsolin, the crystal structure of which has been solved
recently (16), and scinderin found in higher eukaryotes (17) as well as
fragmin and severin of lower eukaryotes (18, 19). Whereas proteins of
the first group are organized into seven domains like villin, the
members of the second group have an organization similar to the villin
core domain. So far, villin is unique among these proteins because it
is the only one that bundles and severs actin filaments in a
Ca2+-regulated manner.
A role for villin in the assembly of the microvillus core bundle was
determined by reconstitution experiments in vitro (20). Addition of villin and fimbrin, another actin-bundling protein associated with the microvillar core, to homogenous F-actin is sufficient for the formation of bundles with a basic structure similar
to that of the brush border microvilli in vivo. Villin overproduction or villin mRNA ablation in cultured cells also suggested that villin supports assembly of the actin core bundle of
microvilli (21-23). Fibroblast-like cells transfected with a cDNA
encoding villin (21) or microinjected with villin protein (22) are
covered by long microvilli containing bundled actin filaments to which
villin is associated. Mutational analysis of villin showed that these
morphological modifications require the first half of the core, also
named villin 44T, and the headpiece domain (see Fig. 1B and
Refs. 21 and 24). The headpiece domain of human villin contains at its
carboxyl terminus a cluster of predominantly basic residues (KKEK),
which is essential for the morphogenic activity of villin in
transfected cells (25). Peptides derived from this region or
recombinant headpiece bind to F-actin (25, 26). The second repeat of
the core domain (V2) comprises a stretch of basic residues (27)
that is important for the severing activity of the 44T villin subdomain
(28). It is likely that this sequence also participates in bundling of
actin filaments in vivo and in vitro. However,
such a mechanism of action has, to our knowledge, never been tested experimentally.
To address the action mechanism of villin, we determined how
mutations affecting villin-induced growth of microvilli in transfected cells can also affect activity of villin in vitro. Because
information obtained from previous studies (21, 25) suggests that
microfilament bundling is an important activity for villin function, we
focused on the two F-actin-binding sites located in the headpiece and core domain, respectively. We have also investigated for the first time
how residue substitutions influencing F-actin binding properties of
villin-derived peptides or domains affect the activities of the whole
villin molecule in vitro.
We show that F-actin bundling but not nucleation activity of villin is
important for induction of F-actin spikes in transfected cells,
suggesting that villin may stabilize and organize the F-actin bundle of
microvilli but might not initiate the formation of these structures.
Reagents
Rhodamine-conjugated phalloidin was purchased from Sigma.
N-Pyrenyliodoacetamide was obtained from Molecular
Probes (Eugene, OR).
Antibodies
Monoclonal antibodies (ID2C3)
recognizing an epitope in the carboxyl terminus of human villin, as
well as their purification was described previously (29).
Fluorescein-coupled anti-mouse IgG antibodies were purchased from
Cappel (Organon Teknika, Turnhout, Belgium). Phosphatase coupled
anti-mouse IgG antibodies were obtained from Amersham Pharmacia Biotech.
Construction of Recombinant DNAs
cDNA constructions were prepared by standard procedures as
described by Sambrook and colleagues (30).
DNA Constructions for Production of Wild Type Villin or Villin
Variants in Eukaryotic Cells--
For expression in eukaryotic cells,
a cDNA encoding wild type villin (4) was inserted into the pCB6
expression vector comprising a cytomegalovirus promoter sequence.
To introduce the double amino acid substitution R137A,K144A, a
sense-primer specific of bp1
403-436 of the human villin coding sequence and an antisense primer
located ~500 bp downstream of this sequence were used in a polymerase
chain reaction. Both primers contained add-on sequences for subcloning,
corresponding to a XbaI and an EcoRI site,
respectively. The sense-primer was a 41-mer oligonucleotide:
5'-CCCTCTAGACGTCCAGGCGCTGCTGCATGTCAAGGGCGCGA-3' (the mutations are underlined). The sequence of the antisense primer was complementary to bp 888-903 of the villin coding sequence, located upstream of the unique BglII restriction site of the
villin sequence. The resulting polymerase chain reaction products were ligated through XbaI and EcoRI into the pSp64
vector. An ~180-bp fragment corresponding to the mutagenized villin
5'-sequence was removed from this construct by AatII and
BglII digestion and ligated to the
AatII/BglII-cut pSp64-villin yielding pSp64-villin RK/AA. A
DNA fragment of 2.7 kilobase pairs encoding the mutagenized complete
villin sequence was ligated through the
XbaI/EcoRI sites into the pCB6 expression vector,
yielding pCB6-villin RK/AA that encodes villin variant RK/AA.
A third amino acid substitution was introduced into the villin protein
sequence by a similar cloning strategy using a 46-mer oligonucleotide
5'-CCCTCTAGACGTCCAGGCGCTGCTGCATGTCAAGGGCGCGGAGAAC-3' as mutagenic primer (the mutations are underlined). The resulting construct was named pCB6-villin RKR/AAE and encodes the villin variant
R137A,K144A,R145E.
DNA Constructions for Production of Wild Type Villin or Villin
Variants in Escherichia coli--
For expression in E. coli, all cDNAs were introduced into the prokaryotic pGEX-2T
expression vector (31). For in-frame ligation to the 3'-end of the
glutathione S-transferase coding sequence, the 5'-end of the
villin cDNA coding region was modified by the polymerase chain
reaction. For expression of the cDNA encoding the triple
substitution variant RKR/AAE in E. coli, the pCB6-villin RKR/AAE DNA was SmaI/EcoRI-digested. An
~2.4-kilobase pairs DNA fragment corresponding to bp 51-2481 of the
villin coding sequence was removed. To reconstitute the entire villin
coding sequence, this fragment was ligated into the
SmaI/EcoRI-cut pGEX-2T-villin 5' DNA.
Constructions of mutant cDNAs encoding villin V1-3+HP, villin
Transient Expression of cDNAs in Cells
The human HeLa cell line derived from a carcinoma of the cervix
and the fibroblast-like CV-1 cells, derived from green monkey kidney
(32) were grown in Dulbecco's minimum essential medium supplemented
with 10% fetal calf serum at 37 °C under a 10% CO2 atmosphere. HeLa and CV-1 cells were transfected using the
Ca2+-phosphate DNA precipitation method as described by
Matthias and colleagues (33). Cells plated on 3.5-cm dishes were
transfected by addition of 5 µg of DNA. Cells were processed for
immunofluorescence or for analysis of proteins by immunoblotting
36 h after addition of DNA.
Immunoblotting
Transfected HeLa cells plated on 3.5-cm dishes were processed
for immunoblotting as described previously (21). One-twentieth of each
cell lysate was used for analysis by immunoblotting. Proteins were
separated by SDS-polyacrylamide gel electrophoresis under reducing
conditions (34). Transfer onto nitrocellulose membrane and antibody
incubations were performed according to the method described by
Burnette (35). Purified monoclonal antibodies were used as first
antibodies (5 µg/ml). Proteins were detected using phosphatase-coupled anti-mouse IgG antibodies following the
manufacturer's instructions (Amersham Pharmacia Biotech).
Fluorescent Labeling of the Cells
Transfected CV-1 cells plated on coverslips were fixed with 3%
paraformaldehyde, detergent permeabilized with 0.4% Triton X-100, and
labeled as described (36). For indirect immunofluorescence staining of
villin, cells were incubated with purified monoclonal anti-villin
antibodies (5 µg/ml) and then with mouse IgG-specific antibodies
conjugated to fluorescein. To visualize F-actin, rhodamine-conjugated phalloidin (0.3 µg/ml) was added at the same time as the secondary antibodies. In some experiments, cells were treated with 0.5% Triton
X-100 for 20 s prior to fixation and immunostained as described (25).
Production and Purification of Proteins
Actin was prepared from rabbit skeletal muscle and labeled with
N-pyrenyliodoacetamide as described (25, 37, 38) and kept in
G buffer (2 mM Tris-HCl, pH 7.2, 0.2 mM ATP, 1 mM dithiothreitol, 0.2 mM
CaCl2).
Villin-glutathione S-transferase fusion proteins were
purified from the soluble fraction of sonicated E. coli BL21
bacteria by glutathione-Sepharose chromatography following standard
procedures. The bead-bound fusion protein was digested with thrombin
(purified from human plasma; Sigma). Thrombin was removed by incubating eluates in the presence of p-aminobenzamidine agarose beads
(Sigma) for 30 min at 4 °C. Proteins were dialyzed against storage
buffer (39). For longer storage or concentration of proteins, eluates were dialyzed against storage buffer containing 50% glycerol and kept
at Electron Microscopic Analysis of Bundling and Severing
Activities
To test bundling activity, 15 µM G-actin in G
buffer was polymerized by addition of 150 mM KCl and 1 mM MgCl2 for 3 h at 20 °C. F-actin and
villin proteins were dialyzed against buffer A (5 mM
KH2PO4, pH 7, 150 mM KCl, 1 mM MgCl2, 2 mM EGTA, 1 mM dithiothreitol). F-actin (3 µM) was
incubated overnight at 8 °C with wild type villin or villin variants
at concentrations indicated under "Results." To study severing,
incubation of 2 µM F-actin and 0.7 µM
protein was performed for 1 min in the presence of 1 mM
CaCl2 at 20 °C. Actin filaments were negatively stained
by addition of 1% uranyl acetate in acetate buffer, pH 5.5, and
observed with an electron microscope on carbon-coated grids.
Sedimentation of Protein with F-actin
F-actin (3 µM) in buffer A, diluted from a 15 µM stock solution was incubated with 0.7 µM
wild type villin or villin variants in the same buffer for 10 min at
20 °C. F-actin was sedimented for 15 min at 30 psi in a Beckman
Airfuge or for 15 min at 200,000 × g in a Beckman
TL100 ultracentrifuge. The pellet and the acetone-precipitated proteins
of the supernatant were resuspended in 15 µl of Laemmli sample buffer
(34) containing 1 mM dithiothreitol and analyzed by
SDS-polyacrylamide gel electrophoresis. Coomassie Blue-stained proteins
were quantified by densitometry using VilberLourmat software. The value
found for protein cosedimenting with F-actin was corrected for the
amount of protein that sedimented in the absence of F-actin. Trapping
of soluble proteins in the pellet, as estimated by sedimenting F-actin
in the presence of bovine serum albumin (5 µg/50 µl) was negligible
under the experimental conditions used.
Actin Polymerization or Depolymerization Assays by Fluorescence
Spectroscopy
Fluorescence measurements were performed at room temperature
using an SFM25 Kontron Instrument or a Spex FluoroMax fluorimeter. The
excitation wavelength was set at 365 nm, and the emission wavelength
was set at 388 nm with a sample volume of 700 µl.
Severing of Actin Filaments--
Severing activity of proteins
was analyzed by the approach described by Janmey and Matsudaira (13).
Actin (2 µM, 100% pyrenyl-labeled) was polymerized in F
buffer (5 mM Tris-HCl, pH 7.2, 1 mM
MgCl2, 150 mM KCl, 0.2 mM ATP, 1 mM dithiothreitol), overnight at 4 °C. F-actin was
diluted below the critical concentration of the pointed end (300 nM) into F buffer containing 200 µM
CaCl2 or 2 mM EGTA and incubated with villin or
villin variants at concentrations indicated under "Results." The
depolymerization rate has been shown to be proportional to the number
of pointed ends and thus to the number of cuts introduced by villin. To
compare the severing activity of wild type villin to that of villin
variants, we measured the decrease in fluorescence/min in the linear
range of the curve as described previously (41).
Nucleation of Actin Polymerization--
To test the nucleating
activity of villin and villin variants, we measured their effect on the
initial phase of actin polymerization. G-actin (2 µM,
50% pyrenyl-labeled) in G buffer containing 20 µM
CaCl2 or 2 mM EGTA, depending on the
experiment, was preincubated in the presence of villin proteins for 10 min on ice. Polymerization was induced by addition of 150 mM KCl and 1 mM MgCl2. The increase of fluorescence was measured over time.
Capping of Actin Filaments--
The capping activity of villin
and villin variants was measured as described by Eichinger and
colleagues (42). Preformed unlabeled actin filaments (800 nM) diluted into F buffer from a stock of 3 µM F-actin, were used as "nuclei" for the
polymerization of G-actin (6 µM, 33% pyrenyl-labeled).
Villin proteins were preincubated with F-actin nuclei in F buffer
containing 20 µM CaCl2 or 2 mM EGTA for 10 min on ice. The F-actin-villin mixture was rapidly added to
monomeric actin in G buffer containing 20 µM
CaCl2 or 2 mM EGTA, and polymerization was
induced by addition of 100 mM KCl and 1 mM
MgCl2. The increase of fluorescence was measured over time.
Production of Wild Type Villin and Villin Variants in Transfected
Cells--
We wanted to determine whether the F-actin-binding site
located in the subdomain 2 (V2) of the core is important for formation of F-actin bundles in cells (Ref. 27 and Fig.
1A). To inactivate this site,
we replaced both Arg137 and Lys144 by the
neutral amino acid alanine (Fig. 1B, villin RK/AA). These substitutions when introduced individually have been shown to reduce
severing activity of villin 44T by 83 and 55%, respectively (28). We
also constructed a triple mutant in which, in addition to the first two
substitutions, Arg145 was replaced by glutamic acid (Fig.
1B, villin RKR/AAE). The corresponding three residues of the
gelsolin sequence, Arg161, Arg168, and
Arg169 are contained within a solvent-exposed structural
entity that is essential for interactions of gelsolin with F-actin
(16).
Production of wild type villin and the two variants in HeLa cells,
transfected with the corresponding cDNAs inserted into a eukaryotic
cytomegalovirus-derived expression vector, was analyzed by
immunoblotting using villin-specific antibodies (Fig. 1C). Specific protein bands of an apparent molecular mass of 95 kDa, corresponding to that of human villin, could be detected in lysates of
cells transfected with wild type villin, villin RK/AA, or villin RKR/AAE. No protein band was detected in the lysate of mock-transfected HeLa cells (control). The amounts of wild type villin or of villin variants produced in transfected cells were similar.
The Stretch of Basic Residues Located in V2 of Villin Is Important
for the Reorganization of the Actin Cytoskeleton in Transfected
Cells--
Overproduction of wild type human villin in transfected
fibroblast-like CV-1 cells results in the growth of microvilli and in a
reorganization of the underlying actin cytoskeleton into spike-like
structures. The appearance of these structures is frequently accompanied by the disruption of stress fibers (21). We used these
phenotypic modifications as an assay for villin activity in cultured cells.
Transiently transfected cells were double-labeled to visualize F-actin
and wild type villin or villin variants (Fig.
2, A-I). The dorsal face of
cells producing the wild type villin were covered by spike-like F-actin
structures (Fig. 2, A and B). A plane of focus at
the ventral face of the same cell showed the absence of stress fibers
(Fig. 2C). In contrast, prominent stress fibers were visible
in neighboring untransfected cells. A similar organization of F-actin
into surface spikes was observed in cells producing the RK/AA variant
(Fig. 2, D and E); however, it was at a lower frequency than when compared with wild type villin (wild type villin:
30%; villin RK/AA: 20%). In contrast, 70% of the cells producing the
RK/AA variant presented disrupted stress fibers (Fig. 2F), a
value that was almost identical to that found with wild type
villin.
Substitution of an additional third basic residue (residue 145) by a
glutamic acid drastically affected the morphogenic activity of villin.
The triple substitution variant RKR/AAE did not induce F-actin spikes
nor did it disrupt stress fibers efficiently (Fig. 2, G-I).
The dorsal face of a cell producing this variant (Fig. 2, G
and H) was covered by small F-actin structures corresponding to the cytoskeleton of small microvilli found on untransfected cells.
The immunofluorescence staining codistributed with the phalloidin label
of these structures as shown in the insets of panels
G and H of Fig. 2. To better visualize codistribution
of villin label with that of F-actin spikes, cells were treated with the nonionic detergent Triton X-100, thereby removing the excess of
cytoplasmic villin. Interestingly, although wild type villin (Fig.
2J) and villin RK/AA (Fig. 2K) remained
associated with F-actin spikes, the RKR/AAE variant (Fig.
2L) was almost totally extracted. In a few cells, this
variant decorated structures (Fig. 2L) that
corresponded to the cytoskeleton of small microvilli (data not shown).
Production of Wild Type Villin and Villin Variants in E. coli--
To correlate the effects observed with villin variants on
the organization of the actin cytoskeleton in cells with in
vitro activities, we produced these variants in E. coli
and determined their properties in assays for actin bundling, severing,
nucleation, and capping. We analyzed variants carrying truncations or
substitutions of basic residues in sequences located in the villin
headpiece (villin
Recombinant variants of villin, produced as glutathione
S-transferase fusion proteins and subsequently cleaved by
thrombin, were analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 3). Wild type villin, villin Substitutions of Basic Residues in the F-actin-binding Sites of the
Core and Headpiece Domains Affect Bundling Activity--
We
determined whether residue exchanges in the headpiece and core domain
impairing villin-induced rearrangement of F-actin into bundles in
transfected cells (Fig. 1B) also affect bundling activity of
villin in vitro. Experiments were carried out at
physiological ionic strength (150 mM KCl) at pH 7, conditions under which villin efficiently bundles actin filaments (43).
In addition, because subtle variations of villin:actin molar ratios
have important consequences on bundle formation, we analyzed bundling
activity at saturating quantities of villin relative to actin
(villin:actin 1:2; Ref. 43), in the presence of EGTA (Fig.
4). In the sample containing F-actin
alone, single or intermingled curved filaments were detected (Fig.
4A). When wild type villin was added to F-actin, straight
bundles with closely aligned filaments were observed (Fig. 4,
B and B'). The villin V1-3+HP variant comprising
the two F-actin-binding sites (Fig. 1, A and B)
was also able to induce the formation of actin bundles but to a lesser
extent, as suggested from the presence of a large number of free
filaments (Fig. 4D). Higher magnification images showed that
actin filaments were more loosely packed in these bundles (Fig.
4D') than in those observed in the presence of wild type
villin (Fig. 4B'). The Both F-actin-binding Sites Are Required for Efficient Binding to
F-actin in the Absence of Ca2+--
Experiments with
villin-derived peptides and domains suggested that truncated or
substituted residues in the
Most of wild type villin and the V1-3+HP variant (Fig. 5A),
was found in the pellet fractions (71% and 73% of total protein, respectively). In contrast, the amount of villin All Villin Variants Retain Severing Activity--
Because the
RKR/AAE variant was still able to bundle actin filaments, we wanted to
determine whether these substitutions would affect severing activity of
the whole villin polypeptide. Severing activity was measured by
analyzing the effect of villin and villin variants on the
depolymerization of pyrenyl F-actin diluted to a concentration below
the critical concentration of the pointed end. We studied severing at
KCl and CaCl2 concentrations (150 and 200 µM,
respectively) allowing the detection of differences in activity between
wild type villin and villin domains produced by limited proteolysis
(13). The RKR/AAE variant was still able to sever actin filaments in a
concentration-dependent manner. However, depolymerization
curves observed in the presence of equal concentrations of wild type
villin or RKR/AAE variant showed that the severing activity of the
mutant was reduced 2-fold (Fig.
6A). Severing activity of the
RKR/AAE variant was also analyzed by electron microscopy. As observed
with wild type villin, F-actin filaments were drastically shortened
when incubated in the presence of the RKR/AAE mutant (data not
shown).
We have also analyzed the severing activity of the V1-3+HP variant and
the headpiece mutants. The depolymerization curve in the presence of
V1-3+HP variant was not significantly different from that of wild type
villin (Fig. 6B). Truncations or substitutions in the villin
headpiece domain (villin Domains 4-6 of Villin Are Required for Efficient Actin Nucleation
but Not for Villin-induced Growth of Microvilli--
Villin may induce
growth of microvilli by initiating the assembly of new microvilli. In
this case, nucleating activity of villin may be required for actin
oligomer recrutment at the inner face of the plasma membrane. Villin
44T, a proteolytical fragment corresponding to domains 1-3, does not
efficiently nucleate in vitro (13). Thus, it was important
to determine whether villin variant V1-3+HP, which still induces the
growth of microvilli, retains nucleating activity (Fig.
7).
In comparison with the polymerization kinetics of actin alone, the
addition of villin (6 or 12 nM) in the presence of 20 µM Ca2+ abolished the lag phase and increased
the initial rate of actin polymerization (Fig. 7A). In
comparison with wild type villin, the V1-3+HP variant had very little
nucleating activity, even when up to 30 nM of V1-3+HP was
added (Fig. 7A). It is noteworthy, however, that the lag
phase of polymerization kinetics was still reduced when V1-3+HP was
added. Variants with deletions or substitutions in the F-actin-binding
sites accelerated the rate of actin polymerization as well as wild type
villin (data not shown). Villin or villin variants did not affect the
polymerization rate of actin in the absence of Ca2+ (Fig.
7B). These results suggest that nucleating activity is not
required for villin-caused reorganization of the actin cytoskeleton in
transfected cells.
We have also analyzed the capping activity of wild type villin and
villin variants by measuring their effect on the polymerization rate of
pyrenyl-labeled G-actin in the presence of short filaments, used as
"nuclei". All villin variants capped actin filaments with an
activity which was indistinguishable from that of wild type villin
(data not shown).
Villin is a cell type-specific, multifunctional actin-binding
protein that has been proposed to participate in the assembly of the
actin core bundle of the intestinal brush border. We analyzed amino
acid sequences important for villin-induced growth of microvilli in
transfected cells and determined which of the villin in
vitro activities are required for its morphogenic effect. We
produced for the first time full-length, recombinant villin and villin variants comprising residue replacements. We found that the activity of
recombinant human villin was similar to that previously reported for
villin purified from tissue. The capacity of villin variants to
organize actin filaments into tight bundles in vitro and to bind efficiently to F-actin is closely related to their ability to
induce microvilli in cultured cells (Table
I). In contrast, nucleation of actin
polymerization in vitro is not correlated with induction of
microvilli by villin (Table I). Hence, villin may participate in the
organization and stabilization of the F-actin core bundle in
vivo but most likely does not "nucleate" the microvillar cytoskeleton by stalilizing actin oligomers at the plasma membrane.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
7, and villin KKEK/KEEE have been described previously (24, 25). For
insertion of these cDNAs into the pGEX-2T expression vector, DNA
fragments encoding these variants but lacking 50 bp of the 5'-end and
the start of translation were ligated into the SmaI/SalI digested pGEX2T-villin SalI
DNA to replace the wild type villin sequence and to reconstitute the
villin 5'-end.
20 °C. We used this storage procedure because we noticed that
storing villin in liquid nitrogen considerably lowered its bundling
activity when compared with freshly prepared protein. Protein
concentration was determined by the Bradford procedure (40) or by
densitometry of Coomassie Blue stained protein bands separated on
SDS-polyacrylamide gels, using bovine serum albumin as a standard.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (30K):
[in a new window]
Fig. 1.
Properties of wild type villin,
villin-derived proteolytical fragments, or genetically engineered
variants. A, domain organization of the primary structure of
villin (filled boxes) and in vitro activities of
chicken wild type villin and villin-derived fragments obtained by
limited proteolysis of villin. Repeats forming the core domain are
numbered from 1 to 6. Domain 7 corresponds to the headpiece domain.
Numbers given in parentheses correspond to
residue positions of the wild type villin sequence. The positions of
hinge regions between core and headpiece or between domains 1-3 and
domains 4-7 are indicated (black lines). Wild type villin
caps, nucleates, severs, and bundles actin filaments in a
Ca2+-dependent manner. Although the core domain
retains Ca2+-dependent capping, nucleating, and
severing activity, the headpiece binds to F-actin in a
Ca2+-independent manner (for review see Refs. 3-5). The
in vitro activity of the villin fragment termed 44T (domains
1-3) is similar to that of the core with the difference that
nucleating activity is highly reduced (13). The carboxyl-terminal
fragment named 55T (domains 4-7) binds actin monomers in a
Ca2+-dependent manner (13). B,
effects of villin and genetically engineered villin derivatives on the
organization of the actin cytoskeleton in transfected cells. The domain
organization of wild type villin and villin variants is shown. Position
numbers corresponding to the wild type human villin amino acid sequence
are given for deleted or replaced residues. Residues are indicated in
one-letter codes. The capacity of these polypeptides to induce the
formation of spike-like F-actin structures forming the cytoskeleton of
microvilli and to disrupt stress fibers is indicated. Villin V1-3+HP
(24),
7, and KKEK/KEEE effects (25) have been described previously.
The effects observed with villin RK/AA and RKR/AAE are described in the
present study. C, production of wild type human villin and
V2 amino acid replacement variants. HeLa cells were transfected with
cDNAs encoding wild type villin or villin variants. 24 h after
addition of DNA, equal amounts of cell lysates were analyzed by
immunoblotting using monoclonal antibodies directed against the
headpiece domain of villin. control, mock-transfected cells.
Molecular mass markers are indicated in kilodaltons.

View larger version (115K):
[in a new window]
Fig. 2.
Effects of wild type and villin variants on
F-actin organization in transiently transfected CV-1 cells. Cells
were transfected with DNAs encoding wild type villin or villin mutants.
A
I, cells were fixed with 3% of paraformaldehyde and
double-labeled for F-actin and villin as described under
"Experimental Procedures." The left panels are
micrographs of the immunofluorescence staining. The middle
and right panels are micrographs of the corresponding
stained F-actin. The left and middle panels
represent a plane of focus on the dorsal face of the cells. The
right panels represent a plane of focus on the ventral face
of the cells. A
C, wild type villin. Spike-like F-actin
structures are distributed over the dorsal cell face and stress fibers
at the ventral face are disrupted in the villin-positive cell.
D
F, villin RK/AA. This variant causes similar phenotypic
modifications as those observed with wild type villin. G
I,
villin RKR/AAE. A cell producing this variant does not exhibit long
F-actin spikes but punctuated F-actin structures corresponding to the
cytoskeleton of small microvilli. Stress fibers are still present at
the ventral face of the cell. Insets in G and
H show the codistribution of the RKR/AAE variant with the
small F-actin structures. J-L, cells were extracted with
0.5% Triton X-100 for 20 s before fixation and labeling for
villin. J and K, villin label remains associated
with long F-actin spikes after detergent extraction of cells producing
wild type villin or villin RK/AA. L, the villin RKR/AAE
variant is almost totally extracted. Bar, 15 µm.
7 and KKEK/KEEE) or core domain (RKR/AAE) that
inactivate villin in transfected cells (25, Figs. 1B and 2)
and are involved in binding to F-actin (25, 26, 28). We have also
analyzed a villin variant composed of the first half of the core domain and the headpiece, named villin V1-3+HP, that retained in
vivo activity (Ref. 24 and Fig. 1B).
7, villin
KKEK/KEEE, and villin RKR/AAE migrated as expected at 95 kDa, whereas
villin V1-3+HP had an apparent molecular mass of 60 kDa.
Proteins of lower molecular masses were identified by immunoblotting as
villin degradation products (data not shown).

View larger version (68K):
[in a new window]
Fig. 3.
Production of wild type villin and villin
variant in E. coli. Purified recombinant villin
or villin variants produced in E. coli were separated by SDS
gel electrophoresis under reducing conditions. About 2 µg of protein
was loaded per lane. Protein bands were revealed by Coomassie Blue
staining. Molecular mass markers are indicated in kilodaltons.
7 variant lacking the seven last
residues, including the KKEK motif of the headpiece domain (Fig.
1B), was inactive for bundling, even at higher molar ratios
of villin to actin (2:1; Fig. 4C). Substitution of lysines
821 and 823 in the headpiece domain (KKEK/KEEE variant: Ref. 25 and
Fig. 1B) almost completely abolished bundling activity. In
samples incubated in the presence of this variant only a few bundles
with loosely associated filaments could be observed (Fig. 4E) exclusively at high villin to actin ratios (2:1).
Surprisingly, triple replacements in the charged sequence of V2 of the
core domain did not significantly affect the extent of bundle formation (Fig. 4F). However, bundles formed in the presence of the
RKR/AAE variant were irregularly shaped, and higher magnification
images revealed that they contained loosely packed filaments to which electron dense material was associated (Fig. 4F').

View larger version (152K):
[in a new window]
Fig. 4.
F-actin bundling by villin and villin
variants. Electron micrographic images of negatively stained
preparations containing 3 µM F-actin and purified
recombinant villin or villin variants. A, F-actin alone;
B and B', 1.5 µM villin.
C, 6 µM villin
7; D and
D', 1.5 µM V1-3+HP; E, 6 µM villin KKEK/KEEE; F and F', 1.5 µM villin RKR/AAE. B', D', and
F' are electron micrographs showing actin bundles visualized
in B, D, and F at a higher
magnification. Bars: E, 0.2 µm, same
magnification for A, B, and D-F;
F', 0.1 µm, same magnification for B' and
D'.
7, KKEK/KEEE, or RKR/AAE variants
participate in F-actin binding (25, 28). We therefore tested whether
loss or reduction of bundling activity correlated with reduced binding
affinity of villin variants for F-actin in cosedimentation experiments
performed in the absence of Ca2+ (Fig.
5).

View larger version (39K):
[in a new window]
Fig. 5.
Cosedimentation of villin and villin variants
with F-actin in the absence of Ca2+. A, villin
(0.6 µM) or villin variants (villin V1-3+HP, 0.9 µM; villin
7, 1.2 µM; KKEK/KEEE, 0.9 µM; RKR/AAE, 0.9 µM) were incubated in the
presence (lanes 1) or absence (lanes 2) of 3 µM F-actin in polymerization buffer containing 2 mM EGTA. After incubation and centrifugation, proteins
contained in the pellets (lanes P) or supernatants
(lanes S) were analyzed by separation on a 7%
SDS-acrylamide gel under reducing conditions. Protein bands were
revealed by Coomassie Blue staining. The protein migrating below the
43-kDa actin band corresponded to a degradation product of this
protein, as determined by sequencing. B, increasing amounts
of villin, villin KKEK/KEEE, or villin RKR/AAE were sedimented with 3 µM actin. Bound villin was plotted as a function of total
villin. Values represent the mean of three independent experiments.
Bars represent the standard deviation.
7 recovered in the
pellet was not greater than that sedimenting in the absence of F-actin
(Fig. 5A). Also at higher molar ratios of villin
7 to
actin (3:3) this variant was not recovered in the pellet fraction (data
not shown), suggesting that this variant has completely lost the
ability to bind to F-actin. In agreement with in vivo observations predicting a reduced affinity for the KKEK/KEEE variant (25), cosedimentation of this polypeptide with F-actin was less efficient (41%) when compared with wild type villin (71%). The core
domain of villin does not bind to F-actin in the absence of
Ca2+ (9). Thus, it was interesting to note that the RKR/AAE
variant also showed reduced ability to cosediment with F-actin (44%). Although affinity constants for these F-actin-binding sites cannot be
calculated for the entire villin molecule, curves obtained by plotting
the amount of bound protein as a function of total protein indicated
that headpiece and V2 substitution variants have a reduced affinity for
F-actin in the absence of Ca2+ (Fig. 5B).

View larger version (17K):
[in a new window]
Fig. 6.
Ca2+-dependent severing activity of
villin or villin variants. Pyrenyl-labeled actin filaments were
diluted under the critical concentration of the (
) end. Severing by
villin or villin variants was measured as a decrease in fluorescence
because of rapid depolymerization at the newly created pointed ends.
Graphs represent the decrease of relative fluorescence intensity
plotted as a function of time. The fluorescence scale was adjusted so
that the fluorescence of F-actin was 100 and that of G actin was 0. A, F-actin was diluted in polymerization buffer containing
villin (60 nM) or RKR/AAE (35 or 60 nM) in the
presence of 200 µM Ca2+. Control,
depolymerization of F-actin in the absence of severing protein.
B, F-actin was diluted in polymerization buffer containing
200 µM Ca2+ and villin (60 nM) or
V1-3+HP (60 nM). Control, depolymerization of
F-actin in the absence of severing protein. C, F-actin was
diluted in polymerization buffer containing 2 mM EGTA and
villin (60 nM), V1-3+HP (60 nM), or RKR/AAE
(60 nM). Control, depolymerization of F-actin in
the absence of severing protein.
7 or KKEK/KEEE) did not affect severing
activity (data not shown). The severing activities of all villin
variants were Ca2+-dependent. When EGTA
was added, depolymerization rates of F-actin in the presence of wild
type villin, villin RKR/AAE, or V1-3+HP were almost identical to that
of F-actin alone (Fig. 6C).

View larger version (24K):
[in a new window]
Fig. 7.
Ca2+-dependent
nucleating activity of villin and villin variants. A, to
evaluate the nucleating activity, the effect of villin (6 and 12 nM) or V1-3+HP (12 and 30 nM) on the initial
rate of polymerization of 6 µM actin in the presence of
20 µM CaCl2 was determined. Polymerization
was started by addition of 150 mM KCl and 1 mM
MgCl2 to G buffer containing G-actin and nucleating
protein. Control, polymerization of actin in the absence of
nucleating protein. The increase of relative fluorescence intensity is
plotted in function of time. B, the effect of villin (12 nM) or V1-V3+HP (12 and 30 nM) on the initial
rate of polymerization of 6 µM actin in the presence of 2 mM EGTA. Control, polymerization of actin in the
absence of nucleating protein.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Summary of the activities of wild type villin and villin variants in
transfected cells and in vitro
7, and KKEK/KEEE on the cytoskeleton of transfected or microinjected
cells have been described previously (21, 22, 24,
25).
The V1-3+HP variant comprising the minimal structural information necessary for elongation of microvilli in transfected cells (24) does not nucleate actin polymerization in vitro, as compared with wild type villin (Table I). Based on this finding and the observation that villin 44T does not nucleate at low 44T to actin ratios, it is likely that one of the actin monomer-binding sites required for nucleation is located in domains 4-6. In this regard, it is interesting to note that a natural variant of mouse adseverin lacking the fifth repeat of its gelsolin-like core by an alternative splicing event lost specifically its nucleating capacity (44). Similarly, it has been shown for the closely related gelsolin polypeptide that not G1-3 but G2-G6 nucleates actin polymerization (45, 46).
Separated villin core or headpiece domains do not bundle actin filaments in vitro (10). We found that the V1+HP variant cosediments with F-actin to a similar extent as wild type villin and bundles actin filaments. This finding suggests that F-actin-binding sites comprised in the first half of the core domain and the headpiece are functional and participate both in bundling. However, because the bundles were less tightly packed than those observed with wild type villin, it is likely that the lack of the second half of the core domain affects the structural organization of the villin domains and may at least partially explain why the activity of this variant in cultured cells is reduced (Ref. 24 and Table I).
The seven carboxyl-terminal residues of the headpiece and particularly
the included KKEK motif are essential for villin function in
transfected cells (24). Our results show that the loss or reduction of
the morphogenic activity of villin
7 and KKEK/KEEE, respectively,
correlates with the loss or reduction of their F-actin binding and
bundling activities in vitro (Table I). These findings emphasize the importance of the KKEK motif in the binding of villin to
actin, as suggested from work with villin-derived peptides (25).
Because villin core alone does not cosediment with F-actin in the
absence of Ca2+ (10), it is likely that K821E,K823E
substitutions do not totally inactivate the F-actin-binding site
located in the headpiece but reduce its affinity for F-actin.
Replacement of Lys823 by cysteine has little effect on the
binding of the headpiece domain to actin in vitro
(26). We have not analyzed the effect of K823E substitution in
vitro, because this mutation does not affect villin activity in
the transfection assay. Therefore, we cannot exclude the possibility
that only Lys821 but not Lys823 is directly
involved in actin interactions. However, NMR-resolved structure of the
carboxyl-terminal subdomain of the headpiece revealed that these
residues cluster on one face of an
-helix and are likely to be both
in contact with actin (47, 48). Because each residue contributes a
fraction of the total binding energy, single mutations in polypeptides
may only partially inhibit binding to F-actin (28).
Domain 2 of villin contains an F-actin-binding site that is important for severing activity and for docking villin to F-actin in the presence of Ca2+ (28, 27). Replacements of three basic residues (Arg137, Lys144, and Lys145) in full-length villin reduced its binding to F-actin in vitro and its avidity for microfilaments in transfected cells, confirming that these residues are part of an F-actin site, as suggested from work with villin-derived peptides (Table I and Ref. 28). Villin core does not bind F-actin binding in the absence of Ca2+ (9). The observation that substitutions in the V2 domain reduce F-actin binding affinity of full-length villin in the absence of Ca2+ suggests that the sites located in the headpiece and core domain are both implicated in binding and that binding of the V2 site may occur in a cooperative manner.
Triple substitutions (RKR/AAE) in the V2 site impaired actin spike formation (Table I), suggesting that this site is required for actin bundle formation in cells. In addition, this villin variant had a reduced capacity to disrupt stress fibers. In parallel, we observed that these substitutions affected both bundling and severing activity in vitro. However, may be due to the presence of domains 4-7, their effect on the severing activity of full-length villin was less severe as expected from the results obtained with the 44T villin fragment (28). Similarly, whereas mutations in the F-actin-binding site of the headpiece domain rendered villin incapable of bundling, the triple RKR/AAE replacement variant still generated actin bundles that were, however, less well organized and exhibited electron dense material along their sides. Thus, because the F-actin-binding site located in the villin core is involved in severing and bundling, we cannot exclude the possibility that both activities are important for villin function in cells.
Although F-actin spike formation and disruption of stress fibers
appeared to be closely coupled, it is noteworthy that loss of stress
fibers can be observed independently of spike formation in cells
producing wild type villin (21). In line with this observation, it has
been shown that the microinjected core domain disrupts stress fibers in
cells (Ref. 22 and Table I). Whether the loss of stress fibers is
solely a consequence of F-actin severing is not yet clear. For
instance, it is not excluded that villin may destabilize stress fibers
by competing with other actin-binding proteins (21). Indeed, the villin
variant
7 retains full severing activity yet does not efficiently
disrupt stress fibers (Ref. 25 and Table I). The difference in the
capacity of villin core and
7 to disrupt stress fibers (Refs. 22 and
21 and Table I) may be explained by distinct properties of these
variants or by the fact they were introduced into cells by different
approaches, microinjection and transfection, respectively.
Altogether, our data suggest that the F-actin-binding site of the headpiece domain has a unique function in the formation of actin filament bundles. Weak hydrophobic interactions of this sequence with actin might be stabilized by electrostatic interactions involving the KKEK motif. The neutralization of the negative charges exposed at the surface of the actin filament may favor their alignment into bundles, as proposed from F-actin bundling studies with polycationic agents in vitro (49). Subsequently, the F-actin-binding site of the V2 subdomain would then cross-link the aligned microfilaments. We do not know yet how villin induces the elongation of actin filaments in transfected cells. It is interesting to note that T plastin, which is exclusively a bundling protein, is able to induce growth of microvilli in transfected epithelial cells (50). A mechanism involving changes of the rates of association or dissociation of monomers from the filaments ends, as shown for the 30-kDa bundling protein of Dictyostelium (51), remains to be carefully evaluated.
Recently it has been shown that brush border assembly is not impaired
in villin minus mice (52), indicating that villin function may be
redundant with that of other bundling proteins of the brush
border such as fimbrin or espin (50, 53). However, brush border of
intestinal cells in villin-minus mice does not undergo
Ca2+-induced actin filament fragmentation as observed for
that of wild type animals (54). This observation opens the possibility that by virtue of its severing activity, villin may play a role in
remodeling the actin cytoskeleton during physiological situations such
as repair of lesions of the intestinal epithelium.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Jean-Claude Benichou for technical help with electron microscope and photographic work. We also thank Dr. R. M. Golsteyn for reading the manuscript and for helpful comments.
| |
FOOTNOTES |
|---|
* This work was supported by grants of the Association pour la Recherche Contre le Cancer and of the Center National de Recherche Scientifique, France.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Recipient of a short-term EMBO fellowship. To whom correspondence should be addressed. Tel.: 33-1-42-34-63-70; Fax: 33-1-42-34-63-77; E-mail: Evelyne.Friederich@curie.fr.
Recipient of a long-term EMBO fellowship.
| |
ABBREVIATIONS |
|---|
The abbreviation used is: bp, base pair(s).
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bretscher, A.,
and Weber, K.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
2321-2325 |
| 2. |
Matsudaira, P. T.,
and Burgess, D. R.
(1979)
J. Cell Biol.
83,
667-673 |
| 3. | Bretscher, A. (1991) Annu. Rev. Cell Biol. 7, 337-374[CrossRef] |
| 4. | Arpin, M., and Friederich, E. (1992) in Epithelial Organization and Development (Fleming, T. P., ed) , pp. 245-271, Chapman and Hall, London |
| 5. | Heintzelman, M. B., and Mooseker, M. S. (1992) Curr. Top. Dev. Biol. 26, 93-122[Medline] [Order article via Infotrieve] |
| 6. | Bretscher, A., and Weber, K. (1980) Cell 20, 839-847[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Craig, S. W., and Powell, L. D. (1980) Cell 22, 739-746[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Mooseker, M. S.,
Graves, T. A.,
Wharton, K. A.,
Falco, N.,
and Howe, C. L.
(1980)
J. Cell Biol.
87,
809-822 |
| 9. | Glenney, J. R., Jr., Kaulfus, P., and Weber, K. (1981) Cell 24, 471-480[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Glenney, J. R., Jr.,
and Weber, K.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
2810-2814 |
| 11. |
Arpin, M.,
Pringault, E.,
Finidori, J.,
Garcia, A.,
Jeltsch, J.-M.,
Vandekerckhove, J.,
and Louvard, D.
(1988)
J. Cell Biol.
107,
1759-1766 |
| 12. |
Bazari, W. L.,
Matsudaira, P.,
Wallek, M.,
Smeal, T.,
and Jakes, R.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4986-4990 |
| 13. |
Janmey, P. A.,
and Matsudaira, P. T.
(1988)
J. Biol. Chem.
263,
16738-16743 |
| 14. | Mahajan-Miklos, S., and Cooley, L. (1994) Cell 78, 291-301[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Hofmann, A., Noegel, A. A., Bomblies, L., Lottspeich, F., and Schleicher, M. (1993) FEBS Lett. 328, 71-76[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Burtnick, L. D., Koepf, E. K., Grimes, J., Jones, E. Y., Stuart, D. I., McLaughlin, P. J., and Robinson, R. C. (1997) Cell 90, 661-670[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Kwiatkowski, D. J., Stossel, T. P., Orkin, S. H., Mole, J. E., Colten, H. R., and Yin, H. L. (1986) Nature 323, 455-458[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Ampe, C., and Vandekerckhove, J. (1987) EMBO J. 6, 4149-4157[Medline] [Order article via Infotrieve] |
| 19. |
André, E.,
Lottspeich, F.,
Schleicher, M.,
and Noegel, A.
(1988)
J. Biol. Chem.
263,
722-727 |
| 20. |
Coluccio, L.,
and Bretscher, A.
(1989)
J. Cell Biol.
108,
495-502 |
| 21. | Friederich, E., Huet, C., Arpin, M., and Louvard, D. (1989) Cell 59, 461-475[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Franck, Z.,
Footer, M.,
and Bretscher, A.
(1990)
J. Cell Biol.
111,
2475-2485 |
| 23. | Costa de Beauregard, M.-A., Pringault, E., Robine, S., and Louvard, D. (1995) EMBO J. 14, 409-421[Medline] [Order article via Infotrieve] |
| 24. |
Finidori, J.,
Friederich, E.,
Kwiatkowski, D. J.,
and Louvard, D.
(1992)
J. Cell Biol.
116,
1145-1155 |
| 25. | Friederich, E., Vancompernolle, K., Huet, C., Goethals, M., Finidori, J., Vandekerckhove, J., and Louvard, D. (1992) Cell 70, 81-92[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Doering, D. S., and Matsudaira, P. (1996) Biochemistry 35, 12677-12685[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Pope, B., Way, M., Matsudaira, P. T., and Wedds, A. (1994) FEBS Lett. 338, 58-62[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
de Arruda, M.,
Bazari, H.,
Wallek, M.,
and Matsudaira, P.
(1992)
J. Biol. Chem.
267,
13079-13085 |
| 29. |
Dudouet, B.,
Robine, S.,
Huet, C.,
Sahuquillo-Merino, C.,
Blair, L.,
Coudrier, E.,
and Louvard, D.
(1987)
J. Cell Biol.
105,
359-369 |
| 30. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 31. | Smith, D. B., and Johnson, K. S. (1988) Gene (Amst.) 67, 31-40[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Jensen, F. C.,
Girardi, A. J.,
Gilden, R. V.,
and Koprowski, H.
(1964)
Proc. Natl. Acad. Sci. U. S. A.
52,
53-64 |
| 33. | Matthias, P. D., Bernard, H. U., Scott, A., Brady, G., Hashimoto-Gotoh, T., and Schütz, G. (1982) EMBO J. 2, 1487-1492 |
| 34. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Burnette, W. N. (1981) Anal. Biochem. 112, 195-203[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Reggio, H., Webster, P., and Louvard, D. (1983) Methods Enzymol. 98, 379-395[Medline] [Order article via Infotrieve] |
| 37. |
Spudich, J. A.,
and Watt, S.
(1971)
J. Biol. Chem.
246,
4866-4871 |
| 38. |
Brenner, S. L.,
and Korn, E. D.
(1983)
J. Biol. Chem.
258,
5013-5020 |
| 39. |
Hesterberg, L. K.,
and Weber, K.
(1983)
J. Biol. Chem.
258,
359-364 |
| 40. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-252[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Gettemans, J.,
De Ville, Y.,
Waelkens, E.,
and Vandekerckhove, J.
(1995)
J. Biol. Chem.
270,
2644-2651 |
| 42. |
Eichinger, L.,
Noegel, A. A.,
and Schleicher, M.
(1991)
J. Cell Biol.
112,
665-676 |
| 43. |
Matsudaira, P. T.,
and Burgess, D. R.
(1982)
J. Cell Biol.
92,
648-656 |
| 44. |
Robbens, J.,
Louahed, J.,
De Pestel, K.,
Van Colen, I.,
Ampe, C.,
Vandekerckhove, J.,
and Renauld, J. C.
(1998)
Mol. Cell. Biol.
18,
4589-4596 |
| 45. |
Kwiatkowski, D. J.,
Janmey, P. A.,
and Yin, H. L.
(1989)
J. Cell Biol.
108,
1717-1726 |
| 46. |
Sun, H.-Q.,
Wooten, D. C.,
Janmey, P. A.,
and Yin, H. L.
(1994)
J. Biol. Chem.
269,
9473-9479 |
| 47. | Simenel, C., Rose, T., Goethals, M., Vandekerckhove, J., Friederich, E., Louvard, D., and Delpierre, M. (1995) Int. J. Peptide Res. 45, 574-586 |
| 48. | McKnight, C. J., Matsudaira, P. T., and Kim, P. S. (1997) Nat. Struct. Biol. 4, 180-184[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Tang, J. X.,
and Janmey, P. A.
(1996)
J. Biol. Chem.
271,
8556-8563 |
| 50. |
Arpin, M.,
Friederich, E.,
Algrain, M.,
Vernel, F.,
and Louvard, D.
(1994)
J. Cell Biol.
127,
1995-2008 |
| 51. |
Zigmond, S. H.,
Furukawa, R.,
and Fechheimer, M.
(1992)
J. Cell Biol.
119,
559-567 |
| 52. | Pinson, K., Dunbar, L., Samuelson, L., and Gumucio, D. L. (1998) Dev. Dynam. 211, 109-121[CrossRef][Medline] [Order article via Infotrieve] |
| 53. |
Bartles, J. R,
Zheng, L.,
Li, A.,
Wierda, A.,
and Chen, B.
(1998)
J. Cell Biol.
143,
107-119 |
| 54. | Ferrary, E., Cohen-Tannoudji, N., Pehan-Arnaudet, G., Lapillonne, A., Athmann, R., Ruiz, T., Boulouha, L., El Mavjov, F., Doye, A., Fontaine, J.-J., Antony, C., Bobinet, C., Louvard, D., Jaisser, F., and Robine, S. (1999) J. Cell Biol., in press |
This article has been cited by other articles:
![]() |
S. P. George, Y. Wang, S. Mathew, K. Srinivasan, and S. Khurana Dimerization and Actin-bundling Properties of Villin and Its Role in the Assembly of Epithelial Cell Brush Borders J. Biol. Chem., September 7, 2007; 282(36): 26528 - 26541. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Revenu, M. Courtois, A. Michelot, C. Sykes, D. Louvard, and S. Robine Villin Severing Activity Enhances Actin-based Motility In Vivo Mol. Biol. Cell, March 1, 2007; 18(3): 827 - 838. [Abstract] [Full Text] [PDF] |
||||